(Q33970434)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787327%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

review article

1 reference

title

'Alzheimer-like' pathology in a murine model of arterial hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787327%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787327%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Giuseppe Lembo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787327%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Daniela Carnevale

series ordinal

1

1 reference

30 July 2017

Giuseppe Lembo

series ordinal

2

1 reference

30 July 2017

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787327%20AND%20SRC:MED&resulttype=core&format=json

Biochemical Society Transactions

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787327%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787327%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787327%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

939-944

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787327%20AND%20SRC:MED&resulttype=core&format=json

The blood-brain barrier in health and chronic neurodegenerative disorders

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Alzheimer disease as a vascular disorder: nosological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Changing perspectives regarding late-life dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Update on hypertension and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Hypertension and cerebrovascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Acute hypertension induces oxidative stress in brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Reactive oxygen species and synaptic plasticity in the aging hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Role of neuroinflammation in hypertension-induced brain amyloid pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Glia and their cytokines in progression of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Role of inflammation in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Taking advantage of the systemic immune system to cure brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939

Systemic infections and inflammation affect chronic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390939